Brightsurf Science News & Current Events

December 01, 2000
Long-term data on Dendreon's Mylovenge™ vaccine presented at American Society of Hematology
Dendreon announces that long-term follow-up data from Phase II trials of its therapeutic vaccine Mylovenge™ were presented at the American Society of Hematology Annual Meeting.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.